Selling a Physical Therapy Practice: Tax Treatment, Valuation, and PE Acquirers (2026)

Outpatient physical therapy is one of the most active healthcare M&A markets in the lower middle market. Private equity has been consolidating PT practices for over a decade, and multiples have remained strong as platform builders compete for established clinics. But selling a PT practice involves tax traps, PE deal mechanics, and visit-volume earnout structures that most owners do not fully understand until it is too late to plan around them.

PT practice M&A landscape in 2026

Outpatient physical therapy is an attractive acquisition target for private equity for structural reasons that have not changed significantly in a decade. The business model features recurring patient relationships, predictable reimbursement (driven by physician referral volume and employer/auto injury claims), low capital intensity compared to surgical specialties, and meaningful operational leverage from PT-to-patient staffing ratios. PE platform builders have been acquiring PT practices since the early 2010s, and the consolidation wave continues in 2026 with both mature platforms adding to existing footprints and newer PE sponsors entering the market.

Types of buyers

PE-backed platform aggregators

The dominant buyer type for PT practices in the $2M–$20M+ EBITDA range is a PE-backed platform aggregator. These companies operate dozens to hundreds of outpatient clinics under a unified brand or multi-brand strategy, with shared billing, credentialing, HR, and marketing infrastructure. They acquire established practices to add patient volume, geographic footprint, and experienced clinical staff — avoiding the ramp time and referral relationship building of a de novo clinic.

PE platform buyers typically offer:

• EBITDA multiples that reflect platform economics — often 8–14× for a practice with strong clinical systems and referral source diversity
• PE rollover equity — keeping 15–30% of your equity in the platform company for a potential second-liquidity event when the PE sponsor sells. This is one of the most financially meaningful parts of a PT practice deal for owners who exit before the platform's peak value. See our PE rollover equity guide for the tax deferral mechanics and second-bite modeling.
• Post-close employment as a clinical director or regional manager, rather than as a pure employee — maintaining clinical autonomy while PE handles business operations

Health systems and hospital networks

Hospital-employed physical therapy is a strategic channel for inpatient-to-outpatient care coordination and referral capture. Hospital buyers may pay prices that reflect referral value rather than standalone EBITDA, but deals with hospital buyers are subject to the same Stark Law and Anti-Kickback Statute FMV requirements that govern physician practice acquisitions. PT services are "designated health services" under the Stark Law, so post-close compensation arrangements must be set at fair market value.²

Physician groups and orthopedic practices

Orthopedic surgery groups with in-house PT operate as a common referral capture model — the same patient who receives surgery at the orthopedic practice completes rehabilitation at the affiliated PT clinic. These deals are often structured as acquisitions of a going-concern PT practice by the ortho group, with the PT owner either staying on as a clinical employee or transitioning out entirely. Multiples are typically lower than PE deals but deal complexity is also lower.

Strategic acquirers and other PT groups

Larger independent PT groups that are not PE-backed may acquire smaller practices to expand geography or capacity. These transactions resemble PE deals in structure but without the rollover equity opportunity and often at lower multiples, since the acquirer is using its own capital rather than PE leverage.

Valuation: EBITDA multiples and key value drivers

Physical therapy practices are valued primarily on a multiple of adjusted EBITDA (earnings before interest, taxes, depreciation, and amortization, normalized for owner compensation and one-time items). Revenue per visit, visits per week, payer mix, therapist-to-patient staffing ratio, and referral source diversity are the key operational metrics buyers scrutinize in diligence.

These ranges reflect lower-middle-market transactions in outpatient PT as of 2026. Actual multiples depend on EBITDA margin, visit growth rate, therapist retention, geographic market, and the specific strategic rationale of the buyer. A sell-side QoE report is typically required to support the normalized EBITDA a buyer will apply their multiple to. See our QoE guide.

Value drivers that expand multiples

• Reduced owner-dependency. A practice that runs at full capacity when the owner is away for two weeks — with clinical director systems in place and referral source relationships distributed across the team — commands a premium. A practice that loses 20% of visits when the owner is out is priced as a job, not a business.
• PT-to-patient staffing leverage. Clinics operating at 2–3 patients per PT per slot (where clinically appropriate and state-law-compliant) generate significantly higher EBITDA margins than 1:1 practices. PE buyers model this explicitly — they buy the clinical capacity, then optimize staffing ratios post-close.
• Payer mix diversification. Workers' compensation, auto injury, and self-pay/cash-pay components reduce Medicare reimbursement dependence and compress-rate risk. A practice with 60% commercial insurance, 20% workers' comp, and 20% Medicare is more attractive than a Medicare-heavy book.
• Referral source breadth. A PT practice where the top three referral sources account for less than 30% of visits is less exposed to the risk that one referring physician retires, joins an in-house PT group, or is acquired by a competitor platform. Buyers discount heavily for referral concentration.
• De novo capability. Evidence that the practice can open a new location and replicate its model — clinical hiring, referral source outreach, operational startup — increases the platform premium PE buyers assign to the acquisition.

Value drivers that compress multiples

• Single-therapist practices. If the practice is essentially the owner's clinical practice with no meaningful enterprise infrastructure, most of the "goodwill" is personal — and PE buyers will price accordingly, often below 5× EBITDA or choosing not to pursue the deal at all.
• Medicare Part B concentration above 50–60%. Medicare sets PT reimbursement rates annually via the physician fee schedule, and rate cuts create margin risk. High Medicare concentration also increases billing compliance scrutiny during diligence.
• Staff turnover and therapist shortages. Physical therapist supply has been constrained relative to demand, and practices with chronic PT vacancy or high annual turnover represent operational and clinical risk that buyers price negatively.
• Facility and lease constraints. A practice in a lease that terminates within 24 months of closing, or with above-market rent that a PE buyer cannot renegotiate, creates deal risk. Buyers want lease terms that match their hold period. See our diligence guide.

QSBS: physical therapy is in the health exclusion

This is the most important tax planning difference between a PT practice sale and a sale of a qualifying business like a manufacturing company or software firm. IRC §1202(e)(3)(A) explicitly excludes "health" from the definition of a Qualified Small Business — and physical therapy is squarely a health service.¹

This means that regardless of how your practice is structured — C-corp, S-corp, or LLC — the stock or membership interests in a physical therapy entity cannot be QSBS. The $15M per-issuer federal exclusion available after the OBBBA (One Big Beautiful Bill Act, July 2025) to manufacturing, technology, and most other business owners does not apply. On a $5M gain, that exclusion would have been worth $1.19M in avoided federal tax (23.8% × $5M). You cannot access it.

This does not mean tax planning is impossible — it means the planning tools are different. Personal goodwill allocation (converting gain taxed at 37% to 23.8%), installment sale deferral, CRT pre-sale contribution, and cash balance plan pre-exit accumulation are the primary levers. An advisor who primarily works with QSBS-eligible technology founders will not necessarily be fluent in these second-tier tools. Ask specifically whether they have experience with healthcare service business exits.

Personal goodwill: the PT owner's primary tax tool

Personal goodwill is the portion of a business's value attributable to an individual's specific relationships, clinical reputation, and expertise — rather than to the business entity's institutional systems and brand. In a physical therapy practice, a meaningful share of what a buyer is paying for is exactly this: the PT owner's patient relationships, the clinical reputation that drives physician referrals, and the professional trust that has accumulated over years of practice.

When properly documented and separately allocated in the purchase agreement, personal goodwill is sold directly by the individual owner to the buyer — bypassing the practice entity entirely. It is taxed as long-term capital gain at the individual's LTCG rate (23.8% federal top rate including NIIT) rather than as ordinary income (up to 37%). On a $3M personal goodwill allocation in a practice sale, the tax difference is approximately $397,000.³

How personal goodwill applies in PT practice sales

Physical therapy personal goodwill arises from:

• Clinical reputation with patients. A therapist with a known specialty — sports rehabilitation, pelvic floor, vestibular, pediatrics, chronic pain — attracts patient self-referrals based on personal reputation rather than the clinic's marketing. This is the clearest form of PT personal goodwill.
• Referring physician relationships. Orthopedic surgeons, sports medicine physicians, and primary care providers who refer to the owner personally — rather than to the clinic brand — hold goodwill that belongs to the owner, not the entity. If the owner retired and the clinic remained open, those referrals would decline.
• Community and professional standing. Published research, speaking engagements, professional society leadership, and teaching affiliations build independent professional reputation that enhances personal goodwill claims.

Documentation requirements

The IRS can challenge personal goodwill allocations made without supporting evidence. Before going to market:

1. Remove entity-level non-competes. If your shareholder or operating agreement contains a non-compete binding you to the entity, the argument that your patient relationships and referral network are yours to sell is significantly weakened. Have this provision removed or confirm it has expired before beginning a sale process.
2. Build your independent professional presence. A PT owner with published case studies, speaking engagements at APTA conferences, or clinical education roles has a stronger personal goodwill argument than one whose identity is entirely tied to the clinic brand.
3. Get a valuation of the personal goodwill component. An independent appraisal that separates personal from enterprise goodwill — supported by referral source attribution analysis and patient relationship documentation — provides the evidentiary foundation the IRS looks for.
4. Negotiate the allocation with the buyer. The purchase agreement must explicitly allocate a portion of the purchase price to personal goodwill sold by you individually. PE buyers are often willing to accommodate this because the allocation is buyer-indifferent for Class VII goodwill — amortized the same way by the buyer regardless of whether it is labeled personal or enterprise goodwill.

See our personal goodwill guide for the governing case law (Martin Ice Cream, Muskat) and full documentation checklist.

Asset sale vs. stock sale

Most PT practice acquisitions by PE platform buyers are structured as asset purchases. Buyers prefer to acquire the clinical equipment, patient charts, lease rights, and goodwill — without inheriting the liabilities of the prior entity. This is particularly important in healthcare transactions where historical billing compliance, malpractice exposure, and employment practices can create post-close liability that buyers are unwilling to accept through a stock acquisition.

The key insight: in most business sales, sellers prefer stock (simpler, avoids recapture). In a PT practice sale, the asset sale can actually be better for the seller — because the personal goodwill allocation opportunity exists only in an asset sale, and that allocation can save far more than the recapture cost on typical PT equipment. Run the numbers before defaulting to a stock sale preference. Our asset vs. stock sale calculator can model both scenarios for your specific numbers.

PE rollover equity: the second bite

When a PE-backed platform acquires your PT practice, the standard deal structure includes an option — and often an expectation — that the selling owner retains 15–30% of their equity in the acquiring platform rather than taking all cash at closing. This rollover equity creates the "second bite of the apple" when the PE firm eventually sells the platform to a larger acquirer or takes it public, typically 4–7 years after your initial transaction.

Why the second bite matters for PT sellers

PT platform consolidation has followed a well-documented pattern: small practices are acquired at 6–8× EBITDA and rolled into a platform, which the PE sponsor eventually sells to a larger fund or strategic buyer at 10–14×. An owner who sells at 7× EBITDA, rolls 20% of their equity, and participates in a platform exit at 12× effectively monetizes at a blended 7.0× on 80% and 12× on 20% — without the operational risk of building the platform themselves.

Tax treatment of rollover equity

Under IRC §351 (for C-corp rollovers) or §721 (for partnership/LLC rollovers), contributing your practice equity in exchange for platform equity is typically a tax-deferred event — you do not recognize gain on the rollover portion at closing. Your tax basis in the new platform equity carries over from your prior basis in the practice equity. Gain is only recognized when you ultimately sell the platform equity. See our PE rollover equity guide for the carryover basis mechanics and second-bite modeling.

Visit-volume earnouts: structure and tax characterization

Earnout provisions in PT practice sales are common and often structured around clinical volume metrics — visits per week, revenue per visit, or total clinical revenue for the first 12–24 months post-close. The earnout addresses buyer risk that the acquired practice's revenue declines post-closing if patients follow the selling therapist to a new employer or if key referral sources redirect volume.

The tax characterization trap

This is where many PT sellers lose money they did not realize they were losing. The tax treatment of payments received after closing depends entirely on whether they are classified as:

• Contingent purchase price installments (capital gain at 23.8%): If the post-closing payments are structured as deferred purchase price — contingent on the practice value holding up — they may qualify for installment sale treatment under IRC §453. See our earnout guide for the complete Temp. Reg. §15a.453-1(c) framework.
• Post-employment compensation (ordinary income at up to 37% + FICA): If the buyer characterizes post-close payments as compensation for continued clinical services or a non-compete, those payments are ordinary income. Most employment-style productivity bonuses and RVU bonuses in a post-close employment agreement are ordinary income regardless of what the seller assumes.

The characterization is set in the definitive purchase agreement — not the employment agreement. If your purchase agreement is silent on how post-close "earnout" payments are classified, and your employment agreement labels them "productivity bonuses," they are compensation. The distinction must be explicitly negotiated before signing.

Non-compete vs. goodwill allocation

Buyers in PT practice acquisitions will require the selling owner to sign a non-compete agreement as a condition of closing. The non-compete prevents the seller from opening or working at a competing PT practice within a defined radius for a defined period — protecting the buyer's investment in the acquired patient relationships.

Why the allocation matters to the seller

Purchase price allocated to a non-compete agreement is classified as a Section 197 intangible (Class VI) by the buyer. From the seller's perspective, proceeds allocated to a non-compete are ordinary income — taxed at rates up to 37% — rather than capital gain taxed at 23.8%. On a $500K non-compete allocation in a PT deal, the tax difference versus goodwill allocation is approximately $65,000.

From the buyer's perspective, both Class VI (non-compete) and Class VII (goodwill) are amortized over 15 years under §197. The buyer's economics are identical either way. This buyer-indifference creates negotiating leverage for the seller: push to allocate as much as possible to goodwill (personal or enterprise) rather than to the non-compete. A buyer who refuses this reallocation is effectively giving up a meaningless tax preference on their end to cost the seller real after-tax proceeds — a reasonable advisor can make this argument persuasively.

Important interaction: if you are claiming personal goodwill, your non-compete is essentially with the acquirer on a personal basis — which supports the personal goodwill argument (you had no prior non-compete with the entity, so the referral relationships were yours to sell). The non-compete allocation and the personal goodwill allocation need to be structured consistently to avoid giving the IRS grounds to challenge either. See our non-compete guide and purchase price allocation guide.

Medicare and commercial payer assignment

Physical therapy practices bill Medicare under two provider types: individual providers (Physical Therapist in Private Practice, PTPP) and institutional outpatient providers (hospital outpatient departments or CORFs). Most independent PT practices bill as PTPP. This billing enrollment is tied to the individual NPI and the practice's group NPI — not to the practice assets themselves.

What happens in an asset sale

In an asset sale, the acquiring entity must establish its own Medicare enrollment before it can bill for PT services provided to Medicare beneficiaries. This involves:

• Obtaining a new group NPI for the acquiring entity
• Submitting new Medicare enrollment applications through PECOS (Provider Enrollment, Chain, and Ownership System) — Form CMS-855B for the group and CMS-855R reassignment for individual therapists
• Credentialing the individual therapists (PT and PTA licenses, NPI, insurance verification) with Medicare and each commercial payer separately
• Renegotiating commercial payer contracts — most commercial insurers do not allow assignment of billing agreements; the new entity must contract directly, which can take 60–180 days

The gap between closing and active payer enrollment creates a real cash flow risk for the buyer — and often a financial terms risk for the seller, as buyers may try to use enrollment delays to trigger purchase price adjustments or earnout measurements that exclude enrollment-gap revenue. The transition services agreement (TSA) — an arrangement under which the seller entity continues billing on behalf of the buyer entity during the enrollment period — is a common solution that requires careful legal and compliance review.

Workers' compensation and auto insurance

PT practices with meaningful workers' compensation or auto injury (PIP) revenue face additional payer transition complexity. Workers' comp billing in most states is employer-specific and case-file-specific — not credentialing-based — but the adjuster relationships that generate consistent case referrals are personal. Auto injury billing typically involves per-case authorization with insurance companies and can be transferred more readily in a stock sale than an asset sale.

NIIT: clinical owner vs. passive investor treatment

The 3.8% Net Investment Income Tax applies to net investment income but not to income from an active trade or business in which the taxpayer materially participates.⁴ A PT practice owner who is actively practicing — treating patients, managing staff, building referral relationships — easily satisfies the material participation tests (more than 500 hours per year in the activity is the most straightforward test).

For a materially participating PT owner:

• Operating income from the practice is not subject to NIIT under the §1411(c)(4) look-through
• Gain on the sale of the practice, to the extent it arises from an active business, is also generally not subject to NIIT for the year of sale — the §1411 regulations treat a materially participating owner's gain as non-passive

The NIIT analysis changes for PT owners who have reduced clinical activity before the sale — for example, an owner who transitioned to an administrative role three years before closing. If you are no longer materially participating in the practice in the year of sale, the gain may be subject to the 3.8% surcharge. The material participation tests are applied annually, so the year of sale is the relevant year. See our NIIT guide for the seven material participation tests and passive activity re-aggregation rules.

Planning timeline: 2–5 years before a PT practice sale

4–5 years before sale: structural and tax strategy

• Assess entity structure for state tax purposes. QSBS is off the table for PT, so a C-corp conversion provides no benefit. However, entity structure affects pass-through taxation during the practice period, the §338(h)(10) election optionality for S-corps, and state-specific corporate practice of healthcare restrictions. Review your entity structure with a healthcare CPA before beginning a sale process. See our S-corp vs. C-corp guide.
• Start a cash balance plan. A PT practice owner aged 50–63 can contribute $150,000–$290,000+ per year to a cash balance plan paired with a 401(k), depending on age, plan design, and employee count. Contributions are deductible against practice income before the sale year, reducing the AGI that will spike at closing. See our cash balance plan guide.⁵
• Document personal goodwill. Remove any entity-level non-compete from your shareholder or operating agreement. Begin building an independent professional presence — clinical publications, APTA presentations, teaching affiliations, state PT association leadership. This record supports a personal goodwill allocation that can save hundreds of thousands in tax.
• Estate planning window. The OBBBA made the $15M per-person estate and gift tax exemption permanent.⁶ Transferring practice equity appreciation to heirs via a GRAT or IDGT funded before the sale is committed can shift a portion of the sale gain to the next generation free of estate and gift tax. See our estate planning guide.

2–3 years before sale: value and marketability

• Reduce owner-dependency. Build a clinical director layer that can handle day-to-day operations and maintain referral relationships independently. PE buyers model post-close performance without the seller; a practice that depends entirely on the founding therapist's presence cannot support a platform-quality multiple.
• Diversify referral sources. If your top three referral sources represent more than 30% of your visits, work to expand relationships with additional physicians, urgent care centers, employer relationships, and self-referral marketing channels before going to market. Referral concentration is consistently one of the largest due diligence issues in PT deals.
• Clean up financial presentation. Normalize owner compensation to market rate in your financials. Identify and document add-backs that a QoE accountant can support — personal vehicle expenses, owner health insurance, owner family salaries above market. Buyers apply their multiple to QoE-adjusted EBITDA; every dollar of defensible add-back is worth 6–12 additional dollars in purchase price.

12–18 months before sale: deal preparation

• Commission a sell-side QoE. A quality-of-earnings analysis by a third-party accounting firm normalizes EBITDA and anticipates buyer questions. For PT practices, the key normalization items are owner compensation, below-market associate pay, and one-time equipment or leasehold expenses. See our QoE guide.
• Engage an exit-planning financial advisor before the LOI. The personal goodwill allocation decision, rollover equity percentage, installment sale feasibility, IRMAA analysis, and post-close cash flow plan all need to be modeled before you receive term sheets — not after you have committed to a structure. An M&A advisor manages the deal process; a fee-only exit-planning advisor manages the financial consequences of the deal.
• Consider a CRT if charitable planning makes sense. If you hold appreciated equity in your practice entity, a charitable remainder trust funded before the sale is legally committed (the binding commitment rule under Rev. Rul. 78-197) avoids capital gains on the contributed equity and generates an income tax deduction. See our CRT guide.

What an advisor models for a PT practice sale

A fee-only exit-planning advisor working on a PT practice sale runs analyses that fall outside what the M&A attorney, investment banker, and deal CPA typically cover:

1. Personal goodwill vs. enterprise goodwill allocation. How much of the purchase price can be defensibly allocated to personal goodwill, and what does that save in federal and state tax? Our business exit after-tax calculator models the deal structure comparison.
2. Rollover equity NPV analysis. Given your rollover percentage, the platform's expected hold period, and a realistic MOIC scenario, what is the expected after-tax value of the rollover position versus taking all cash? Our PE rollover calculator models the second-bite math.
3. Earnout characterization. Is the proposed earnout language in the purchase agreement structured as a contingent installment payment (capital gain) or as employment compensation (ordinary income)? What is the after-tax value difference, and how should the purchase agreement language be changed?
4. IRMAA exposure. A $3M+ practice sale will push the seller's MAGI into the top IRMAA tier for two years, adding surcharges of up to $13,872 per person annually. What deal structuring tools — installment sale, CRT, DAF contribution — reduce the MAGI impact? See our IRMAA guide.
5. Installment sale modeling. If the gain outside the personal goodwill allocation is substantial, a §453 installment note that defers recognition over 3–7 years may keep income in lower brackets and reduce the lifetime tax bill. This decision requires modeling the after-tax present value tradeoff between immediate recognition and deferred recognition. See our installment sale calculator.
6. Post-sale income transition. Practice income ends on closing day. The estimated tax safe harbor (110% of prior-year AGI), Roth conversion window during the lower-income years after sale, and portfolio construction from a concentrated liquidity event all need planning before the wire arrives. See our post-sale planning guide.